Skip to content
Back to Guavy Wire
Stocks

Salesforce Surge Unlikely to Last: Analyst Downgrades to Sell

Instruments
CRM
Share

Salesforce's recent surge of 13% following its Q2 FY27 earnings report is unlikely to be sustained, according to some analysts. The company's revenue growth was driven by inorganic factors and non-recurring EPS items, rather than organic expansion.

Although the company reported that its contract-renewal-percentage-optional (cRPO) growth outpaced revenue, this acceleration may not translate into long-term benefits. Additionally, Salesforce's recent acquisitions have been multiple-dilutive, with initial return on invested capital below the cost of debt.

As a result, the analyst has downgraded their view and is locking in gains, recommending that investors wait for a clear indication of organic growth acceleration before re-entering the market. The current forward GAAP price-to-earnings ratio of 28.8x makes it an attractive time to sell.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc